LifeVantage Corporation

NASDAQ: LFVN · Real-Time Price · USD
11.82
-0.09 (-0.76%)
At close: May 05, 2025, 3:59 PM
12.33
4.31%
After-hours: May 05, 2025, 05:17 PM EDT
-0.76%
Bid 11.53
Market Cap 148.36M
Revenue (ttm) 212.15M
Net Income (ttm) 7.34M
EPS (ttm) 0.57
PE Ratio (ttm) 20.74
Forward PE 11.3
Analyst Buy
Ask 12.82
Volume 106,082
Avg. Volume (20D) 216,991
Open 11.89
Previous Close 11.91
Day's Range 11.79 - 12.23
52-Week Range 5.22 - 27.38
Beta 0.44

About LFVN

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3...

IPO Date Apr 7, 1994
Employees 222
Stock Exchange NASDAQ
Ticker Symbol LFVN
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for LFVN stock is "Buy." The 12-month stock price forecast is $30.5, which is an increase of 158.04% from the latest price.

Stock Forecasts

Next Earnings Release

LifeVantage Corporation is scheduled to release its earnings on May 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-7.82%
Shares of companies within the broader consumer st... Unlock content with Pro Subscription
3 weeks ago
-9.67%
Shares of companies within the broader consumer staples sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.